alexa Biosimilars: Marketing, Development, Regulations And Molecules Approved In Australia, Brazil, Malaysia, Japan, Singapore And South Korea
ISSN: 1948-593X

Journal of Bioanalysis & Biomedicine
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

8th Asian Biologics and Biosimilars Congress
August 10-12, 2017 Beijing, China

Tomas Gabriel BAS
Universidad Catolica del Norte, Chile
Posters & Accepted Abstracts: J Bioanal Biomed
DOI: 10.4172/1948-593X-C1-033
Abstract
The expiration of patents for biological drugs will lead us to the golden age of biosimilars and provide a competitive edge to mediumsized pharmaceutical manufacturers and contract research organizations. Biosimilars are three-dimensional versions of biological products that share an identical protein sequence and common amino acid sequence with the originals (biological drugs) and have demonstrated a high degree of similarity in physicochemical characteristics, efficacy, safety (including immunogenicity) and quality, but with differences in their manufacturing process in the structure of the active protein. However, these biological medicines offer lower-cost alternatives to the original drugs. The paper reviews the literature on biosimilar drugs and covers their therapeutic status, approved biosimilars, and regulatory guidelines in Australia, Brazil, Malaysia, Japan, Singapore and South Korea. The literature suggests that biosimilars are comparable but not identical to the reference product. They are not a generic version of an innovative product and do not ensure therapeutic equivalence. Each country has its own regulatory guideline for biosimilar drugs.
Biography

Tomas Gabriel BAS is Director of Center of Innovation and Entrepreneurship and executif director of MBA at Universidad Catolica del Norte (Coquimbo) Chile. He was the director of Institute of Innovation based on Science, University of Talca (Chile). Director of Masters in Technology Management and Director of Masters in Technology Management with emphasis in Biotechnology from the same university in Talca. Manager founder and editor of scientific journal (SciELO) "Journal of Technology Management & Innovation" (www.jotmi.org). Editor invited of the journal “BioMed Research International” (ISI). Director and co-director of national and international projects in Biotechnology and innovation and knowledge-based industries Natural Resources. Advisor to United Nations Economic Commission for Latin America (ECLA) in Biotechnology (Clusters, Public Policy, Technological Innovation Policy). Advisor to the World Bank in innovation and clusters in natural resources. Expert Advisory Committee on Assessment of Economics and Management of National Scientific and Technological Commission (CONICYT) Sciences. Expert Advisory Committee National Assessments and Scientific Technological Development Fund of Chile (FONDECYT).

Email: [email protected]

image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords